Welcome to Quotient Sciences - Garnet Valley (Philadelphia)

Latest news
Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment

Our Philadelphia manufacturing sites have been audited and approved by a range of global regulatory agencies:

United States Food and Drug Administration (FDA)



 

Japanese Pharmaceuticals & Medical Devices Agency (PMDA)

Brazilian Health Regulatory Agency (ANVISA)



 

Chinese National Medical Products Administration (NMPA)

Ministry of Industry and Trade of the Russian Federation

Meet our team

We work with you as partners, sharing a single goal of getting get new treatments to those in need, fast. Meet some of the team members who you'll see or work with when you have a project with us at Philadelphia.

Marlene Leuenberger

VP & General Manager, Quotient Sciences - Philadelphia

Marlene Leuenberger is an established operations leader with over three decades of experience in the pharmaceuticals and consumer ...

About Marlene
Nichole Caparelli

Senior Director, Quality Operations

Nichole Caparelli has over 20 years of experience in small molecule manufacturing from development through commercialization with ...

About Nichole
Amit Patel

Senior Director, Technical Services, Formulation Development

Amit Patel, Senior Director of Technical Services, has held various technical and operational leadership roles during his 15-year ...

About Amit
Brad Rowe

Senior Director, Integrated Development

Brad Rowe joined the organization in 2005 and is based from our Philadelphia, PA sites in Garnet Valley and Boothwyn. He joined QS...

About Brad
Dr. Helen Baker

Director, Formulation Design, Analytical Development

Dr. Helen Baker has over 15 years of formulation and product development experience within the pharmaceutical, biotech, and agrono...

About Helen
Robert Cornog

Senior Director, Product Development

Robert Cornog has over 26 years of experience in product development and process design. Across a broad range of dosage forms and ...

About Robert

News from Quotient Sciences - Philadelphia

More News
News & Announcements, Articles & Publications, Artificial Intelligence Andy Lewis on AI‑Enabled Formulation Design and Faster Speed to Clinic By: Andy Lewis
Learn More
News & Announcements, Articles & Publications, Early Drug Development, Artificial Intelligence AI's Role in Fast-tracking Early Drug Development; Our ground breaking alliance with Intrepid Labs By: Andy Lewis
Learn More
News & Announcements, Articles & Publications, Artificial Intelligence Building Trust in AI‑Enabled Formulation: Insights from Quotient Sciences and Intrepid Labs By: Andy Lewis
Learn More
Let's Talk
Humanity can't wait, so neither can we. Discuss your drug program today.